Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that there are multiple ways to create PCOS in animals for research, which helps understand and treat the condition.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

The document concludes that PCOS in teenagers is hard to diagnose, influenced by various factors, and should be managed with lifestyle changes and medication.

The project improved provider knowledge about PCOS but didn't significantly change diagnosis and management practices.

Early hair loss in men may signal broader health issues similar to PCOS in women.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Women with PCOS may have a higher risk of Alzheimer's disease.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

COC treatment improves hormone and metabolic levels in PCOS patients.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Excess androgens may cause PCOS, not just be a symptom.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

PCOS is mainly caused by insulin resistance and can be managed with lifestyle changes, exercise, weight loss, and medications.

Mitochondrial dysfunction and oxidative stress may play a role in Lichen Planopilaris.

Higher ꝩ-GCS enzyme levels in PCOS patients may play a role in the disease.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Silicon may affect calcium metabolism in dialysis patients, causing symptoms like skin eruptions and abnormal hair growth.